Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of Irf6 in tooth epithelial invagination.
Blackburn J, Ohazama A, Kawasaki K, Otsuka-Tanaka Y, Liu B, Honda K, Rountree RB, Hu Y, Kawasaki M, Birchmeier W, Schmidt-Ullrich R, Kinoshita A, Schutte BC, Hammond NL, Dixon MJ, Sharpe PT. Blackburn J, et al. Among authors: honda k. Dev Biol. 2012 May 1;365(1):61-70. doi: 10.1016/j.ydbio.2012.02.009. Epub 2012 Feb 14. Dev Biol. 2012. PMID: 22366192 Free PMC article.
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma.
Kawai T, Kurokawa Y, Taguchi S, Honda K, Maki K, Ambe Y, Saegusa N, Yamamoto M, Miyakawa J, Tokura Y, Inoue H, Tanaka T, Nara K, Kaneko T, Fujii Y, Kamei J, Kakutani S, Yamada Y, Niimi A, Yamada D, Takada T, Nakagawa T, Kume H. Kawai T, et al. Among authors: honda k. Jpn J Clin Oncol. 2025 Jan 15:hyaf001. doi: 10.1093/jjco/hyaf001. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39812300
Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Kodama H, Kadowaki S, Ishizuka Y, Wakabayashi M, Sakakida T, Honda K, Masuishi T, Narita Y, Taniguchi H, Ando M, Kishikawa T, Terada H, Beppu S, Nishikawa D, Suzuki H, Hanai N, Muro K. Kodama H, et al. Among authors: honda k. Int J Clin Oncol. 2025 Jan 14. doi: 10.1007/s10147-025-02698-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39806030
Significant response to tocilizumab in a case of immune deposits-related membranoproliferative glomerulonephritis and tubulointerstitial nephritis complicated by multicentric Castleman's disease.
Sugimoto H, Sawa N, Ikuma D, Oba Y, Mizuno H, Sekine A, Yamanouchi M, Hasegawa E, Suwabe T, Wada T, Kono K, Kinowaki K, Ohashi K, Honda K, Kanetsuna Y, Joh K, Yamaguchi Y, Ubara Y. Sugimoto H, et al. Among authors: honda k. Clin Nephrol Case Stud. 2024 Dec 20;12:73-82. doi: 10.5414/CNCS111337. eCollection 2024. Clin Nephrol Case Stud. 2024. PMID: 39776937 Free PMC article.
Lattice-guided growth of dense arrays of aligned transition metal dichalcogenide nanoribbons with high catalytic reactivity.
Ma Z, Solís-Fernández P, Hirata K, Lin YC, Shinokita K, Maruyama M, Honda K, Kato T, Uchida A, Ogura H, Otsuka T, Hara M, Matsuda K, Suenaga K, Okada S, Kato T, Takahashi Y, Ago H. Ma Z, et al. Among authors: honda k. Sci Adv. 2025 Jan 10;11(2):eadr8046. doi: 10.1126/sciadv.adr8046. Epub 2025 Jan 8. Sci Adv. 2025. PMID: 39772681 Free PMC article.
Single-Molecule Oxidoreductase Activity Analysis for Activity-Based Diagnosis Based on Proteoform Alterations.
Minoda M, Hatakeyama J, Nagano N, Mizuno T, Iwasaka T, Shiga S, Takahashi K, Hiraide H, Sakamoto S, Kagami Y, Kashiro A, Honda K, Sugiura Y, Mishima K, Mishima MK, Kusuhara H, Urano Y, Komatsu T. Minoda M, et al. Among authors: honda k. J Am Chem Soc. 2025 Jan 6. doi: 10.1021/jacs.4c07624. Online ahead of print. J Am Chem Soc. 2025. PMID: 39762186
2,901 results